Michael Levin

Yeah.

Well, yes and no.

I mean, I want to get away from the 3D printing thing because that will be available for some things much earlier.

I mean, we can already do bladders and ears and things like that because it's micro level control, right?

When you 3D print, you are in charge of where every cell goes.

And for some things that, you know, for like this thing, they had that, I think, 20 years ago or maybe earlier than that, you could do that.

Yeah.

The main magic would be, I mean, I think from looking at Dali and so on, it looks like the first part is kind of solved now, where you go from the words to the image.

Like, that seems more or less solved.

The next step is really hard.

This is what keeps things like CRISPR and genomic editing and so on, that's what limits all the...

impacts for regenerative medicine because going back to, okay, this is the knee joint that I want, or this is the eye that I want.

Now, what genes do I edit to make that happen, right?

Going back in that direction is really hard.

So instead of that, it's going to be, okay, I understand how to motivate cells to build particular structures.

Can I rewrite the memory of what they think they're supposed to be building such that then I can, you know, take my hands off the wheel and let them, let them do their thing.

It is.

I think where, and we're doing some of this now, is to use AI to try and build actionable models of the intelligence of the cellular collectives.

So try to help us gain models that... And we've had some success in this.

So we did something like this for...